http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2739131-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f220ff41ebe4c7f2e7da8ec7e7e9dca
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-007
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2020-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_881ffc78d053abbf5ec20eff7c28447c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a65e4be1aebe7b0bbb674c2dad9c51fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b71fdb577d79514d46988d73c8cb321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e830d711ac71400f00219f995af45f4
publicationDate 2020-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2739131-C1
titleOfInvention Method of surgical treatment of foveoshisis with preservation of foveal fragment of internal limiting membrane
abstract FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to ophthalmology. Three-port chromovitrectomy is performed using Triamcinolone acetonide dye. Internal limiting membrane (ILM) is contrast-enhanced with membrane blue 0.15 % dye. Using endovitreal tweezers, ILM is captured 2 mm from an upper temporal arcade, and an ILM flap is formed in the form of a strip with length of 8–10 mm, with width of 1–2 mm. One of edges of this flap is grasped as in fig. 1, it is separated by direction to center of fovea, not reaching 2.0 mm to fovea zone. That is followed by successively forming three flaps of ILM in the form of lobes as follows: the first one – along the edge of the formed flap in the form of a strip. Then the second, and the third – from the remaining ILM section. All the flaps are separated towards the center of the fovea. Further, the vitreous cutter cuts edges of all ILM flaps, leaving a foveal region of a rounded foveal ILM fragment with diameter of 4 mm. Operation is terminated by removing the ports.EFFECT: method enables eliminating retinal traction, reducing intraoperative injuries, preserving an anatomical profile of the fovea region, reducing the rehabilitation period and improving the quality of vision of high-degree myopia.1 cl, 3 ex, 1 dwg
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2763825-C1
priorityDate 2020-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6436
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453686569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359264
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546247

Total number of triples: 24.